Omnicell
OMCL
318 hedge funds and large institutions have $2.66B invested in Omnicell in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 127 increasing their positions, 108 reducing their positions, and 39 closing their positions.
67% more call options, than puts
Call options by funds: $6.21M | Put options by funds: $3.72M
18% more repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 108
18% more capital invested
Capital invested by funds: $2.26B → $2.66B (+$396M)
1.51% less ownership
Funds ownership: 102.06% → 100.55% (-1.5%)
3% less funds holding
Funds holding: 329 → 318 (-11)
18% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$34.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.6M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$15.5M |
| 4 |
Rockefeller Capital Management
New York
|
+$13.2M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$12.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.4M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$26.6M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$21.6M |
| 4 |
Swedbank
Stockholm,
Sweden
|
-$17.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$15.6M |
OMCL Hedge Fund Activity: Q1 2023 in Review
318 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q1 2023, worth a combined $2.66B — up 18% from $2.26B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of OMCL and 32 opened new positions — a net loss of 7 holders — while 108 trimmed existing stakes and 127 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $34.2M. The largest seller was Fidelity Investments, cutting an estimated $29.4M.
- 318 institutional investors held Omnicell (OMCL) as of Q1 2023, down from 329 in Q4 2022.
- Funds reported $2.66B of Omnicell stock for Q1 2023, up 18% quarter-over-quarter.
- 32 funds opened new Omnicell positions in Q1 2023 and 39 closed out, a net change of -7 holders.
- The largest Omnicell buyer in Q1 2023 was Point72 Asset Management, an estimated $34.2M added.
- The largest Omnicell seller in Q1 2023 was Fidelity Investments, an estimated $29.4M sold.
Based on aggregated 13F filings for Q1 2023.